What is the difference between Spravato and IV ketamine near Islip?
Spravato is an FDA-approved esketamine nasal spray for specific adult depressive disorders and requires certified administration in a clinic. IV ketamine is an off-label, compounded formulation lacking FDA psychiatric approval, often operating on a self-pay basis. Both approaches require clinical supervision and a mandatory post-treatment observation period.
Can I drive home to Islip after a Spravato session?
No, driving after treatment is strictly prohibited. Because the medication temporarily impairs motor skills, coordination, and cognition, you must have a trusted, responsible adult drive you home to Islip. Driving can only be safely resumed the following day after you have gotten a completely restful night's sleep.
How long do observation appointments take at Long Island clinics?
A standard Spravato appointment typically lasts between two and two-and-a-half hours. This includes the time needed to properly administer the medication and a mandatory two-hour post-treatment clinical observation period. This monitoring ensures staff can address potential side effects, such as sedation or increased blood pressure.
Will my insurance cover ketamine therapy in Suffolk County?
Insurance coverage varies widely. FDA-approved Spravato may be covered for eligible patients, though it usually requires prior authorization from your carrier. Off-label treatments like IV or IM ketamine are generally not covered by insurance and rely on self-pay. Always contact your insurance provider directly for details.
Is ketamine therapy for depression FDA-approved?
Spravato (esketamine) is the only formulation FDA-approved specifically for treatment-resistant depression and depression with acute suicidal ideation in adults. Other forms of ketamine, such as IV infusions or compounded lozenges, are utilized off-label and do not carry formal FDA approval for any psychiatric uses.
Can I take Spravato at home in Islip?
No, Spravato is never administered at home. Safety regulations strictly require that it be administered in a certified medical setting under direct clinical supervision. While some providers prescribe off-label ketamine for home use, the FDA strongly warns against the risks of unmonitored home administration.